Ricardo Weinlich (R Weinlich)

Publication Activity (10 Years)

Years Active: 2015-2023
Publications (10 Years): 3

Top Topics

Drug Administration

Patient Reported

Tyrosine Kinase

Top Venues

Journal of neuro-oncology

Cell death and differentiation

Expert opinion on biological therapy

University of São Paulo (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of São Paulo Feb 01 2003 - Oct 31 2008

Brazil

PHD :: Immunology

Publications

Edina Poletto, Andrew Oliveira Silva, Ricardo Weinlich, Priscila Keiko Matsumoto Martin, Davi Coe Torres, Roberto Giugliani, Guilherme Baldo
Ex vivo gene therapy for lysosomal storage disorders: future perspectives. Expert opinion on biological therapy (2023)
Guilherme Afonso Vergara, Gisele Cristine Eugenio, Suzana Maria Fleury Malheiros, Elivane da Silva Victor, Ricardo Weinlich
Higher Mixed lineage Kinase Domain-like protein (MLKL) is associated with worst overall survival in adult-type diffuse glioma patients. PloS one 18 (8) (2023)
Guilherme Afonso Vergara, Gisele Cristine Eugenio, Suzana Maria Fleury Malheiros, Elivane da Silva Victor, Ricardo Weinlich
RIPK3 is a novel prognostic marker for lower grade glioma and further enriches IDH mutational status subgrouping. Journal of neuro-oncology 147 (3) (2020)
D A Rodriguez, Ricardo Weinlich, S Brown, C Guy, P Fitzgerald, C P Dillon, A Oberst, Giovanni Quarato, J Low, J G Cripps, T Chen, D R Green
Characterization of RIPK3-mediated phosphorylation of the activation loop of MLKL during necroptosis. Cell death and differentiation 23 (1) (2015)